Lu Bei (鲁贝)鲁贝
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司
主要成分Active Ingredients
- 奈达铂Naida Bo
药物知识说明
奈达铂是一种在国家药监局注册认定的药品。标注生产企业为齐鲁制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司、齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司、齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 鲁贝) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 齐鲁制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司, 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司, 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 鲁贝Recorded Chinese name: 鲁贝
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 10mg。10 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 齐鲁制药有限公司Chinese legal name: 齐鲁制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20050563
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20050563
Manufacturer
Chinese legal name: 齐鲁制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20050563
生产企业
齐鲁制药有限公司(国产)
适应症
本品主要用于头颈部癌，小细胞肺癌，非小细胞肺癌，食管癌等实体瘤。
用法用量
临用前,用0.9%的氯化钠注射液溶解后,再稀释至500ml,静脉滴注,滴注时间不应少于1小时,滴完后需继续点滴输液1000ml以上。推荐剂量为每次给药80-100mg/m2,每疗程给药一次,间隔3-4周后方可进行下一个疗程。
不良反应
1.本品主要不良反应为骨髓抑制，表现为白细胞、血小板、血色素减少;其它较常见的不良反应包括恶心、呕吐、食欲不振等消化道症状以及肝肾功能异常、耳神经毒性、脱发等。
2.其它不良反应虽发生率较低，但应引起关注。
禁忌
1.有明显骨髓抑制及严重肝、肾功能不全者。
2.对其它铂制剂及右旋糖酐过敏者。
3.孕妇、可能妊娠及有严重并发症的患者。
注意事项
1.对恶心、呕吐、食欲不振等消化道不良反应应注意观察,并进行适当的处理。
2.合用其它抗恶性肿瘤药物(氮芥类、代谢拮抗类、生物碱、抗生素等)及放疗可能使骨髓抑制加重。
3.本品配制时,不可与其它抗肿瘤药混合滴注,也不宜使用氨基酸输液?pH5以下的酸性输液(如电解质补液,5%葡萄糖输液或葡萄糖氯化钠输液等)。
4.本品忌与含铝器皿接触。本品在存放及滴注时应避免直接日光照射。?
贮藏
遮光，密闭，30℃以下保存。
规格
10mg。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.